Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Monocytes might be linked to hair loss after COVID-19.

A woman's hair grew back with baricitinib treatment, but she developed a temporary hairy tongue that was treated with regular tongue brushing.

About 61% of women who had COVID-19 experienced hair loss afterward.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

A woman with IgG/IgA pemphigus was treated successfully with dapsone and steroids.

A woman got a serious eye infection after a hair loss treatment due to improper procedure.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

The protein p53 directly reduces the production of Keratin 17, a skin and hair protein, in rats with radiation dermatitis.

Oral feline interferon-omega improved symptoms in diabetic cats with gingivostomatitis.

Targeting a protein that blocks hair growth with microRNAs could lead to new hair loss treatments, but more research is needed.

Mesotherapy is not significantly better than minoxidil for treating male hair loss.

Gloriosa superba poisoning can mimic severe tropical infections and cause rapid hair loss.

Cholesterol-modified siRNAs targeting certain genes increased hair growth in mice.

Botryococcus terribilis and its compounds may promote hair growth and improve hair health.

Deleting the EDAR gene in Cashmere goats affects genes and proteins related to hair growth.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

The chapter explains common scalp conditions, including infections, infestations, and tumors.

Light therapy on the brain shows promise for treating brain diseases and improving brain function.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Cannabinoids may help treat various skin conditions.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Bimatoprost is effective for growing longer, thicker, and darker eyelashes.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

A woman with severe hair loss was successfully treated with the drug adalimumab.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.